文献速递外周动脉疾病

慢性肢体威胁性缺血患者血运重建后临床随访对结局的影响

The Impact of Clinical Follow-Up After Revascularization on the Outcomes of Patients with Chronic Limb Threatening Ischemia.
PubMed 文献 · Ann Vasc Surg · 2022-07-06

本研究为单中心回顾性病历审查,纳入连续接受下肢血运重建的慢性肢体威胁性缺血(CLTI)患者356例,按随访依从性分为依从组(61%,N=218)与不依从组。不依从组更常接受腔内介入(92.8% vs 79.4%,P=0.03);平均随访2.7年后,依从组同侧再干预率(49.1% vs 34.1%,P=0.005)和总体再干预率(61% vs 44.2%,P=0.002)更高,两组死亡率与同侧大截肢率无显著差异。

要点

  • CLTI患者下肢血运重建后随访依从率为61%(218/356)。
  • 不依从组腔内介入比例高于依从组(92.8% vs 79.4%,P=0.03)。
  • 依从组再干预更多,但死亡率与同侧大截肢率无显著差异。

核心结论

  • CLTI患者下肢血运重建后随访依从者接受了更多再干预,但死亡率与大截肢率无差异。
  • 作者指出,关于再干预阈值和CLTI患者最佳随访方案仍需进一步研究。

研究设计与样本

  • 单中心回顾性病历审查,连续纳入因CLTI接受下肢血运重建的患者。
  • 共356例患者,按随访依从性分为依从组(61%,N=218)与不依从组。
  • 比较两组患者特征、再干预及围手术期与长期结局。

主要发现

  • 两组基线特征无显著差异。
  • 不依从组腔内介入比例高于依从组(92.8% vs 79.4%,P=0.03)。
  • 两组围手术期结局无差异,总体30天死亡率为0.6%。
  • 平均随访2.7年后,依从组同侧再干预率高于不依从组(49.1% vs 34.1%,P=0.005)。
  • 依从组总体再干预率高于不依从组(61% vs 44.2%,P=0.002);两组死亡率与同侧大截肢率无显著差异。

局限性

  • 原文报告为单中心回顾性病历审查。
  • 原文结论指出,关于再干预阈值和CLTI患者最佳随访方案仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Guidelines for optimal follow-up for patients undergoing lower extremity revascularization (LER) for peripheral arterial disease recommend multiple visits with imaging during the first year followed by yearly monitoring thereafter. Critical limb-threatening ischemia (CLTI) patients are at a greater risk for mortality and limb amputation than claudicants and thus necessitate closer monitoring. The goal of this article is to study the effects of compliance with follow-up after revascularization for patients with CLTI on major amputation rates and mortality. METHODS: A single-center retrospective chart review of consecutive patients undergoing LER for CLTI was performed. Patients were stratified based on compliance with follow-up to compliant or noncompliant cohorts. Patient characteristics, reinterventions, and perioperative and long-term outcomes were compared between the 2 groups. RESULTS: There were 356 patients undergoing LER and 61% (N = 218) were compliant. There was no significant difference in baseline characteristics between the 2 groups. Noncompliant patients were more likely to undergo endovascular interventions compared to compliant patients (92.8% vs. 79.4%, P = 0.03). There was no difference in perioperative outcomes between the 2 groups with overall 30-day mortality of 0.6%. After mean follow-up of 2.7 years, compliant patients had greater ipsilateral reintervention rates (49.1% vs. 34.1%, P = 0.005) and overall reintervention rates (61% vs. 44.2%, P = 0.002) compared to noncompliant patients. There was no significant difference in mortality or ipsilateral major amputations between the 2 groups. CONCLUSIONS: Patients who were compliant with follow-up after LER for CLTI underwent more reinterventions with no difference in mortality or major limb amputation. Further research regarding the threshold for reintervention and the optimal schedule for follow-up in patients with CLTI is needed.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kiwan G, Mohamedali A, Kim T, et al. The Impact of Clinical Follow-Up After Revascularization on the Outcomes of Patients with Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2022. PMID: 35803459. doi:10.1016/j.avsg.2022.05.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。